SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences informs about settlement agreement

12 Feb 2026 Evaluate

Pursuant to the provisions of regulation 30 of the Listing Regulations, Zydus Lifesciences has informed that the Company and Zydus Pharmaceuticals USA, Inc., USA, a wholly owned subsidiary, (together referred to as ‘Zydus’), have entered into a Settlement Agreement with Astellas in relation to Astellas’ Myrbetriq® (generic name: Mirabegron). This development is in continuation of its earlier intimation dated April 17, 2025, regarding the US patent litigation with Astellas. Under the terms of the Settlement Agreement: 1. Zydus shall pay Astellas an aggregate amount of USD 120 million. 2. Zydus shall additionally pay a prepaid per unit licensing fee on units of Zydus’ generic Mirabegron sold in the US from the date of Settlement Agreement till September 2027. Other terms and conditions of the Settlement Agreement remain confidential. This Settlement Agreement concludes all litigations between Astellas and the two companies relating to Myrbetriq® and Mirabegron and enables Zydus to continue marketing its generic Mirabegron in the US.

The above information is a part of company’s filings submitted to BSE. 

Zydus Lifesciences Share Price

901.65 10.00 (1.12%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.10
Dr. Reddys Lab 1287.95
Cipla 1334.85
Zydus Lifesciences 901.65
Lupin 2350.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×